An accomplished physician–scientist with a career dedicated to biomarker-driven research and practice surrounding the development, early detection, and treatment of kidney cancer, W. Kimryn Rathmell, MD, PhD, took the helm as the National Cancer Institute (NCI) director in December 2023.